Palantir to Sue London Mayor Over Blocked Met Police Contract

What happened

London Mayor Sadiq Khan blocked a £50 million contract extension between Palantir and the Metropolitan Police that would have expanded the company's role from detecting rogue officers to scanning criminal intelligence data for patterns using AI technology. Khan cited concerns about using public funds for firms that "act contrary to London's values" and questioned the procurement process, which did not allow competing bids. Palantir's lawyers have written to the Mayor's Office for Policing and Crime stating their intent to challenge the decision in court, calling it a "politicised decision." The Met criticised the mayor's move, warning that officer numbers may need to be cut without the technology.

Why it matters

The legal challenge represents a significant confrontation between Palantir and UK public officials over the company's government contracts. The dispute centres on whether firms' political associations and external work-in Palantir's case, contracts with the Israeli military and Trump administration's immigration enforcement-should influence procurement decisions for critical public services. For Palantir, the outcome could affect its ability to expand its UK public sector presence beyond its existing £330 million NHS contract. The Met's support for Palantir's position suggests the dispute may also impact law enforcement capabilities, with the force warning about potential operational constraints.

Bigger picture

The contract dispute comes as Palantir faces broader scrutiny in the UK. A parliamentary committee recently called the company's growing public sector presence an "unacceptable point of weakness," citing concerns about reliance on US tech suppliers and data security. Technology minister Liz Kendall confirmed the government is conducting a full review of Palantir's NHS contract, which runs until early 2027 with provisions for extension or termination. Critics have raised concerns about Palantir personnel potentially receiving broad access to identifiable patient data. The controversy reflects wider debates about data sovereignty, national security implications of foreign tech providers, and whether ethical considerations should factor into public procurement alongside technical capabilities and cost.

What to watch

The immediate focus will be on whether Palantir formally files its legal challenge against Khan's decision and whether the Met joins the claim. Investors should monitor the government's NHS contract review, particularly any decision around the 2027 break clause that could terminate the £330 million deal. Further parliamentary pressure or policy changes regarding foreign technology providers in critical public services could affect Palantir's broader UK operations. Any resolution on data access protocols for NHS patient information will also be significant for the company's healthcare business.